These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22260025)

  • 1. [Synthesis and biological evaluation of 3-aromatic Shiff base-5-fluoroindol-2-one derivatives].
    Fang Z; Yang Z; Xu JF; Wang YL; Wang ZX; Wei P
    Yao Xue Xue Bao; 2011 Nov; 46(11):1338-43. PubMed ID: 22260025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis of 1-furfuryl-indolin-2-one derivatives and preliminary evaluation of their antitumor activities].
    Dong XC; Zhou FS; Zheng JB; Wen R
    Yao Xue Xue Bao; 2008 Jan; 43(1):54-9. PubMed ID: 18357732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro Evaluation of Novel Indole-Based Sigma Receptors Ligands.
    Yarim M; Koksal M; Schepmann D; Wünsch B
    Chem Biol Drug Des; 2011 Nov; 78(5):869-75. PubMed ID: 21848665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents.
    Zou H; Zhang L; Ouyang J; Giulianotti MA; Yu Y
    Eur J Med Chem; 2011 Dec; 46(12):5970-7. PubMed ID: 22019188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
    Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 7-azaisoindigo derivatives.
    Wang ZH; Wang T; Yao SN; Chen JC; Hua WY; Yao QZ
    Arch Pharm (Weinheim); 2010 Mar; 343(3):160-6. PubMed ID: 20186868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and in vitro antitumor evaluation of novel diaryl ureas derivatives.
    Sun M; Wu X; Chen J; Cai J; Cao M; Ji M
    Eur J Med Chem; 2010 Jun; 45(6):2299-306. PubMed ID: 20181414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
    Virsodia V; Manvar A; Upadhyay K; Loriya R; Karia D; Jaggi M; Singh A; Mukherjee R; Shaikh MS; Coutinho EC; Shah A
    Eur J Med Chem; 2009 Mar; 44(3):1355-62. PubMed ID: 18316139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and biological evaluation of sorafenib thiourea derivatives].
    Yang Z; Fang Z; Wang ZX; Wei P
    Yao Xue Xue Bao; 2011 Sep; 46(9):1093-7. PubMed ID: 22121780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological evaluation of novel bisindolylalkanes analogues.
    Song YL; Dong YF; Yang T; Zhang CC; Su LM; Huang X; Zhang DN; Yang GL; Liu YX
    Bioorg Med Chem; 2013 Dec; 21(24):7624-7. PubMed ID: 24262885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel DNA intercalators without basic side chains as efficient antitumor agents: design, synthesis and evaluation of benzo-[c,d]-indol-malononitrile derivatives.
    Li X; Wang Q; Qing Y; Lin Y; Zhang Y; Qian X; Cui J
    Bioorg Med Chem; 2010 May; 18(9):3279-84. PubMed ID: 20385497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities.
    Hong S; Kim J; Seo JH; Jung KH; Hong SS; Hong S
    J Med Chem; 2012 Jun; 55(11):5337-49. PubMed ID: 22575050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
    Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
    J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel indole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerase I activities.
    Lafayette EA; de Almeida SMV; Cavalcanti Santos RV; de Oliveira JF; Amorim CADC; da Silva RMF; Pitta MGDR; Pitta IDR; de Moura RO; de Carvalho Júnior LB; de Melo Rêgo MJB; de Lima MDCA
    Eur J Med Chem; 2017 Aug; 136():511-522. PubMed ID: 28531811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "On water" expedient synthesis of 3-indolyl-3-hydroxy oxindole derivatives and their anticancer activity in vitro.
    Sai Prathima P; Rajesh P; Venkateswara Rao J; Sai Kailash U; Sridhar B; Mohan Rao M
    Eur J Med Chem; 2014 Sep; 84():155-9. PubMed ID: 25016373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiproliferative activities of isoindigo and azaisoindigo derivatives.
    Bouchikhi F; Anizon F; Moreau P
    Eur J Med Chem; 2008 Apr; 43(4):755-62. PubMed ID: 17628214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and biological evaluation of 3-quinolinecarbonitrile-7-amide derivatives].
    Liu B; You QD; Li ZY
    Yao Xue Xue Bao; 2009 Aug; 44(8):879-84. PubMed ID: 20055156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
    Marchand P; Antoine M; Le Baut G; Czech M; Baasner S; Günther E
    Bioorg Med Chem; 2009 Sep; 17(18):6715-27. PubMed ID: 19682911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antitumor agent family of 1H-benzo[c,d]indol-2-one with flexible basic side chains: synthesis and biological evaluation.
    Yin H; Xu Y; Qian X
    Bioorg Med Chem; 2007 Feb; 15(3):1356-62. PubMed ID: 17129733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity and COMPARE analysis of bis-indole derivatives.
    Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Landi L; Prata C; Dalla Sega FV; Caliceti C; Shoemaker RH
    Bioorg Med Chem; 2010 May; 18(9):3004-11. PubMed ID: 20395150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.